290 related articles for article (PubMed ID: 33339096)
1. Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation.
Zahran EM; Albohy A; Khalil A; Ibrahim AH; Ahmed HA; El-Hossary EM; Bringmann G; Abdelmohsen UR
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339096
[TBL] [Abstract][Full Text] [Related]
2. New Hopes for Drugs against COVID-19 Come from the Sea.
Taglialatela-Scafati O
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33670191
[TBL] [Abstract][Full Text] [Related]
3. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.
Hossain R; Sarkar C; Hassan SMH; Khan RA; Arman M; Ray P; Islam MT; Daştan SD; Sharifi-Rad J; Almarhoon ZM; Martorell M; Setzer WN; Calina D
Chin J Integr Med; 2022 Mar; 28(3):249-256. PubMed ID: 34913151
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.
Rafiq A; Jabeen T; Aslam S; Ahmad M; Ashfaq UA; Mohsin NUA; Zaki MEA; Al-Hussain SA
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375415
[TBL] [Abstract][Full Text] [Related]
5. The Anti-Viral Applications of Marine Resources for COVID-19 Treatment: An Overview.
Geahchan S; Ehrlich H; Rahman MA
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436248
[TBL] [Abstract][Full Text] [Related]
6. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms.
Riccio G; Ruocco N; Mutalipassi M; Costantini M; Zupo V; Coppola D; de Pascale D; Lauritano C
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32645994
[TBL] [Abstract][Full Text] [Related]
7. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
Takahashi JA; Barbosa BVR; Lima MTNS; Cardoso PG; Contigli C; Pimenta LPS
Bioorg Med Chem; 2021 Sep; 46():116366. PubMed ID: 34438338
[TBL] [Abstract][Full Text] [Related]
8. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.
da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP
Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197
[TBL] [Abstract][Full Text] [Related]
9. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape.
Rampogu S; Gajula RG; Lee G; Kim MO; Lee KW
Comput Biol Med; 2021 Aug; 135():104525. PubMed ID: 34252682
[TBL] [Abstract][Full Text] [Related]
10. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.
Agrawal N; Goyal A
Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805
[TBL] [Abstract][Full Text] [Related]
11. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
12. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.
Li T; Ding T; Li J
Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543
[TBL] [Abstract][Full Text] [Related]
13. Possible Therapeutic Targets from Derivatives of Natural Marine Products Based on PI3K/AKT Dependent Inhibitors in Viral Infection COVID-19.
Aleebrahim-Dehkordi E; Koochaki P; Samami E; Ghoshouni H; Ghadimi DJ; Shadnoush F; Saberianpour S; Rafieian-Kopaei M
Cell Physiol Biochem; 2022 Dec; 56(6):707-729. PubMed ID: 36537138
[TBL] [Abstract][Full Text] [Related]
14. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
[TBL] [Abstract][Full Text] [Related]
15. Marine Natural Products: A Source of Novel Anticancer Drugs.
Khalifa SAM; Elias N; Farag MA; Chen L; Saeed A; Hegazy MF; Moustafa MS; Abd El-Wahed A; Al-Mousawi SM; Musharraf SG; Chang FR; Iwasaki A; Suenaga K; Alajlani M; Göransson U; El-Seedi HR
Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31443597
[TBL] [Abstract][Full Text] [Related]
16. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
[TBL] [Abstract][Full Text] [Related]
18. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
20. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X
Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
